Author

Alyssa L. Verano

Dana-Farber Cancer InstituteORCID 0000-0003-2478-202XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Andrew M. LowyiD· 1 shared Anna M. SchmokeriD· 1 shared Anne G. BangiD· 1 shared Cara R. SchiavoniD· 1 shared Chun‐Teng HuangiD· 1 shared David A. ScottiD· 1 shared Dinah M. Abeja· 1 shared Elena RebolloiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew M. LowyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature Chemical BiologyPeer-reviewedAug 11, 2025

ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC

Nathan L. Tran, Jiewei Jiang, Mengyao Ma…·Fleur M. Ferguson

This study develops ZBTB11 degraders to target metabolic vulnerabilities in K-Ras inhibitor-resistant PDAC, showing improved anti-cancer activity with reduced toxicity to neurons.

12 citationstop 4%

humanproteomics

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedJul 24, 2025

Unveiling the hidden interactome of CRBN molecular glues with chemoproteomics

Kheewoong Baek, Rebecca J. Metivier, Shourya S. Roy Burman…·Eric S. Fischer

The paper identifies 298 protein targets of CRBN-binding molecular glues using a high-throughput affinity purification mass spectrometry workflow and demonstrates a lead compound for the new target PPIL4.

76 citationstop 1%

proteomicsexperimental assay

𝕏 PostBluesky